Fig. 1From: SLERT, as a novel biomarker, orchestrates endometrial cancer metastasis via regulation of BDNF/TRKB signalingSLERT is highly expressed in EC. A, B qRT-PCR analysis of SLERT expression in EC and normal tissues, followed by ROC analysis. C The survival curve of EC patients with low or high SLERT levels based on median SLERT level. D, E qRT-PCR analysis of SLERT expression in EC and normal plasma, followed by ROC analysis. F, G qRT-PCR and FISH testing the location of SLERT in KLE and AN3CA cells. *P<0.05, **P<0.01, ***P<0.001Back to article page